The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.

[1]  J. Ritchie,et al.  Studies of Platelet Factor 4 and Beta Thromboglobulin Release During Exercise: Lack of Relationship to Myocardial Ischemia , 1982, Circulation.

[2]  I. Walker,et al.  A Double Blind Study of Prostacyclin in Cardiopulmonary Bypass Surgery , 1981, British journal of haematology.

[3]  D. Dillard,et al.  Platelet function during and after deep surface hypothermia. , 1981, The Journal of surgical research.

[4]  J. Ritchie,et al.  Studies of human plate alpha-granule release in vivo. , 1981, Blood.

[5]  D. Longmore,et al.  PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MAN , 1981, The Lancet.

[6]  S. Hanson,et al.  Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. , 1981, Blood.

[7]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[8]  K. Rådegran,et al.  Prostacyclin infusion during cardiopulmonary bypass in man. , 1980, Thrombosis research.

[9]  J. Copeland,et al.  Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin. , 1980, Annals of Thoracic Surgery.

[10]  Rw Colman,et al.  Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation , 1979 .

[11]  D. Longmore,et al.  PROSTACYCLIN: A SOLUTION TO SOME PROBLEMS OF EXTRACORPOREAL CIRCULATION Experiments in Greyhounds , 1979, The Lancet.

[12]  J. Vane,et al.  PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGS , 1978, The Lancet.

[13]  Harker La,et al.  Thrombocytopenia: mechanisms and management of defects in platelet production. , 1978, Clinics in haematology.

[14]  C. Beurling-Harbury,et al.  Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. , 1978, Blood.

[15]  R. Sautter,et al.  Platelet dysfunction associated with cardiopulmonary bypass. , 1978, The Annals of thoracic surgery.

[16]  R. Ponlot,et al.  Hæmostasis Disorders in Open Heart Surgery with Extracorporeal Circulation: Importance of the Platelet Function and the Heparin Neutralization , 1977, Vox sanguinis.

[17]  R. Ponlot,et al.  Haemostasis Disorders in Open Heart Surgery with Extracorporeal Circulation , 1977 .

[18]  R. Bick.  Alterations of Hemostasis Associated With Cardiopulmonary Bypass: Pathophysiology, Prevention, Diagnosis, and Management , 1976, Seminars in thrombosis and hemostasis.

[19]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[20]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[21]  L. Harker,et al.  The bleeding time as a screening test for evaluation of platelet function. , 1972, The New England journal of medicine.

[22]  L. Harker,et al.  Thrombokinetics in man. , 1969, The Journal of clinical investigation.